Tower Research Capital LLC (Trc) Dynavax Technologies Corp Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 18,839 shares of DVAX stock, worth $255,833. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,839
Previous 16,873
11.65%
Holding current value
$255,833
Previous $187,000
28.34%
% of portfolio
0.0%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding DVAX
# of Institutions
288Shares Held
131MCall Options Held
507KPut Options Held
374K-
Black Rock Inc. New York, NY21.9MShares$297 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$242 Million10.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$124 Million0.0% of portfolio
-
State Street Corp Boston, MA7.79MShares$106 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ6.56MShares$89.1 Million5.31% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.72B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...